GlassScriptPhysician profile
Michael Ritt Jaff
NPI 1750372884
$42,903.34
in general payments reported to CMS, 2019-2025
7 companies · $52.70 in 2025
The $52.70 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,650 · 2021: $5,372 · 2022: $8,750 · 2023: $11K · 2024: $10K · 2025: $52.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,812.21 |
| Food and Beverage | $319.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Vascular INC | $29,603.60 | 2022-2024 | Hydropicc Dual Lumen, Hydromid Maximal Barrier Kit, Hydropicc Full Kit |
| Medtronic Vascular, INC. | $7,442.22 | 2019 | |
| Silk Road Medical, INC. | $5,289.84 | 2019-2021 | |
| Boston Scientific Corporation | $262.98 | 2021-2024 | Eluvia |
| Philips North America LLC | $167.63 | 2019 | |
| Medtronic, INC. | $74.78 | 2024-2025 | |
| Collaborative Care Diagnostics, LLC | $62.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.